Biography of Dr. Arbinder Singal: Co-founder and CEO of Fitterfly- Entrepreneur
A Journey of Dr. Arbinder Singal: From Medicine to Digital
Innovation
Early Life and Education
Dr. Arbinder Singal’s journey in healthcare began in Mumbai,
India, where he was born and raised. A gifted student from the start, he
pursued his MBBS degree at Maulana Azad Medical College, graduating with top
honors and a gold medal. His pursuit of excellence continued at the All India
Institute of Medical Sciences (AIIMS), where he earned his M.Ch. in Pediatric
Surgery, again achieving gold medalist status. This early success laid the
foundation for his future endeavors in both clinical practice and medical
innovation.
Path to Specialization
After completing his formal education, Dr. Singal’s career
took him to various prestigious institutions. He undertook further training in
Pediatric Urology at Nationwide Children's Hospital in the United States, where
he was awarded the Stecker Scholarship. His extensive training and
international exposure equipped him with a unique perspective on global healthcare
practices and challenges.
The Birth of Fitterfly
In 2016, Dr. Singal co-founded Fitterfly, a digital
therapeutics company based in Navi Mumbai. Along with co-founders Shailesh
Gupta and Jayesh Sawant, Dr. Singal aimed to address the growing concerns
around diabetes and other lifestyle-related health issues. Gupta, serving as
the COO, and Sawant, working on innovative health solutions, joined Dr. Singal
in this ambitious venture to revolutionize healthcare through technology.
A Personal Challenge
Dr. Singal’s personal encounter with diabetes in 2019 played
a pivotal role in shaping Fitterfly’s mission. Having a family history of
diabetes and experiencing prediabetes himself, he was driven by a personal
stake in finding effective solutions. This diagnosis spurred him to combine his
medical expertise with technological innovation to tackle diabetes more
effectively.
Innovating Diabefly Pro
In response to his own health challenges, Dr. Singal and his
team at Fitterfly developed Diabefly Pro, a digital therapeutics program
designed to manage diabetes. The program integrates continuous glucose
monitoring with a comprehensive nutrition database to provide users with
personalized insights into their glycemic responses to various foods,
ultimately helping them make better dietary choices.
Introducing New Concepts
Dr. Singal’s work also led to the creation of several new
concepts in diabetes management. He introduced terms such as “Personalized
Glycemic Response” and “Glycemic Shock,” which describe the individual
variations in blood sugar responses to different foods and situations. His
collaboration with Jayesh Sawant on Delta/Carb ratios further advanced the
understanding of how different types of carbohydrates affect blood sugar
levels.
Expanding Fitterfly’s Reach
Over the years, Fitterfly has evolved its offerings to
include not only diabetes management but also broader aspects of lifestyle
health. By 2021, the company incorporated psychological support, stress
management, sleep management, and physical fitness into its programs. This
holistic approach aimed to address the various factors contributing to health
and wellness, providing a comprehensive solution for users.
Biography of Dr. Arbinder Singal:Co-founder & CEO of Fitterfly-Entrepreneur/ Investor/Success story of Dr. Arbinder Singal/Age/Net worth/Fitterfly
Commitment to Security and Compliance
In the health-tech industry, ensuring data security and
regulatory compliance is crucial. Fitterfly adheres to stringent data
protection measures, following the Digital Data Protection Bill to ensure user
data is securely encrypted and handled with consent. The company also maintains
certifications such as ISO 27001 for security, ISO 13485 for chronic disease management
technology, and CDSCO certification for software as a medical device.
Digital Therapeutics in India
India, known as the diabetes capital of the world, faces a
significant challenge in managing this widespread health issue. Despite
advancements in medical treatments and testing, the incidence and complications
of diabetes have not significantly decreased. Dr. Singal believes that
technology, particularly digital therapeutics, holds the key to making a
substantial impact in managing diabetes in India.
Leveraging Technology for Better Outcomes
Fitterfly’s approach to digital therapeutics involves using
technology to drive better health outcomes. With over 400 million people in
India having access to smartphones, Fitterfly harnesses this technology to
offer real-time insights and support through its app. This includes continuous
glucose monitoring, educational content, and behavioral therapy to help users manage
their health effectively.
The Evolution of Fitterfly’s Programs
The evolution of Fitterfly’s programs reflects a deep
understanding of user needs and clinical evidence. By integrating continuous
glucose monitoring with personalized nutritional guidance and behavioral
support, Fitterfly offers a comprehensive approach to diabetes management. This
approach is designed to empower users with the tools and knowledge they need to
make healthier choices and achieve better health outcomes.
Fitterfly’s Diabetes Prime Program
The Diabetes Prime Program, one of Fitterfly’s flagship
offerings, represents the culmination of years of research and development. The
program provides real-time glucose monitoring data through the app, allowing
users to see the immediate effects of their dietary choices on blood sugar
levels. This instant feedback helps users make informed decisions and fosters
better management of their condition.
Holistic Health Solutions
Recognizing the multifaceted nature of health, Fitterfly’s
program also includes components such as cognitive behavioral therapy, physical
fitness routines, and community support through group classes. These elements
are designed to address the various dimensions of health, from mental
well-being to physical fitness, creating a well-rounded approach to managing
diabetes.
The Importance of Specialized Knowledge
Dr. Singal emphasizes the importance of having specialized
medical expertise in healthcare technology companies. According to him, the
inclusion of doctors in the leadership team ensures that content and solutions
are scientifically grounded, engaging, and clinically effective. This focus on
clinical outcomes is crucial for ensuring the success and impact of digital
health solutions.
Annual Programs for Long-Term Impact
Fitterfly has introduced annual programs to provide
long-term benefits for individuals with high HbA1c levels. These programs are
designed to offer sustained support and improvements in blood sugar levels over
an extended period, contributing to lasting health benefits and potentially
reducing complications related to diabetes.
Fitterfly’s Growing Influence
With its innovative approach and successful implementation,
Fitterfly is set to expand its influence across India. The company’s focus on
scientifically validated outcomes, user engagement, and holistic health
management positions it as a leader in the digital therapeutics space.
Fitterfly aims to grow its platform and reach more users, leveraging technology
to address one of the most pressing health challenges in India.
Partnerships and Collaborations
Fitterfly collaborates with top doctors, pharmaceutical
companies, insurers, and corporates to enhance its offerings and extend its
reach. These partnerships are vital for integrating Fitterfly’s solutions into
broader healthcare ecosystems and ensuring that its programs are accessible to
a wide audience.
Future Goals and Expansion
Looking ahead, Fitterfly plans to expand its services across
India, aiming to become a leading player in the digital therapeutics field. The
company’s vision includes growing its platform to serve a larger population and
continuing to innovate in the management of chronic conditions like diabetes.
Dr. Singal’s Ongoing Mission
Dr. Singal’s mission remains centered on leveraging
technology to improve health outcomes and manage chronic diseases more effectively.
His personal experiences and professional expertise drive his commitment to
advancing digital therapeutics and making a positive impact on public health.
Impact of Digital Therapeutics
The success of Fitterfly’s digital therapeutics programs
highlights the potential of technology to transform healthcare. By providing
personalized, real-time insights and comprehensive support, digital
therapeutics can significantly enhance the management of chronic conditions and
improve quality of life for individuals.
A Vision for the Future
Dr. Singal’s work with Fitterfly exemplifies the
intersection of medical expertise and technological innovation. His vision for
the future includes continued advancements in digital health solutions and a
broader impact on managing chronic diseases. As Fitterfly grows and evolves, it
remains dedicated to improving health outcomes through cutting-edge technology
and evidence-based practices.
Timeline of Dr. Singal’s story:
Early Life: Born in Mumbai, India, and graduates with MBBS
and M.Ch. degrees, both with gold medals.
2016: Co-founds Fitterfly, a digital therapeutics company.
2019: Diagnosed with prediabetes, driving personal
involvement in Fitterfly’s mission.
2020: Fitterfly launches Diabefly Pro, a diabetes management
program.
2021: Expands Fitterfly’s offerings to include holistic
health solutions.
2024: Fitterfly continues to grow, focusing on comprehensive
digital therapeutics and expanding its reach across India.
